Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cytokines, glucocorticoids and neuroendocrine function

J C Buckingham1, H D Loxley, A D Taylor

  • 1Department of Pharmacology, Charing Cross and Westminster Medical School, London, UK.

Pharmacological Research
|July 1, 1994
PubMed
Summary

Immune system activation affects the brain-neuroendocrine system, specifically the hypothalamo-pituitary-adrenocortical (HPA) axis. Cytokines, glucocorticoids, and lipocortin 1 (LC1) play a critical role in this interplay for host defense.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multiple Influences on Cognitive Function Among Urban-Dwelling African Americans.

Journal of racial and ethnic health disparities·2019
Same author

Sergio Henrique Ferreira (1934-2016).

British journal of pharmacology·2017
Same author

The role of the Annexin-A1/FPR2 system in the regulation of mast cell degranulation provoked by compound 48/80 and in the inhibitory action of nedocromil.

International immunopharmacology·2016
Same author

On the Eicosanoid Trail with John Vane and Jack McGiff: 1974-1976. A personal reminiscence.

Prostaglandins & other lipid mediators·2015
Same author

'Annexins' themed section.

British journal of pharmacology·2015
Same author

Annexin A1 mimetic peptide controls the inflammatory and fibrotic effects of silica particles in mice.

British journal of pharmacology·2015

Area of Science:

  • Neuroendocrinology
  • Immunology
  • Physiology

Background:

  • Immune system activation triggers neuroendocrine changes, notably the hypothalamo-pituitary-adrenocortical (HPA) axis.
  • Glucocorticoids, released via HPA axis activation, are crucial for managing immune responses and restoring homeostasis.

Purpose of the Study:

  • To investigate the impact of immunokines on the HPA axis.
  • To determine if glucocorticoids and lipocortin 1 (LC1) modulate these cytokine-induced HPA axis responses.

Main Methods:

  • In vivo and in vitro experiments were conducted.
  • Interleukin-1 beta (IL-1 beta), IL-1 alpha, IL-6, and IL-8 were administered to assess their effects on HPA axis components.
  • Dexamethasone and lipocortin 1 (LC1) were used to examine modulatory roles.

Related Experiment Videos

Main Results:

  • Interleukin-1 beta (IL-1 beta) administration increased serum corticosterone and corticotrophin-releasing factors (CRF-41, AVP) release, effects reversed by dexamethasone.
  • Cytokines did not directly affect ACTH release from pituitary tissue.
  • Lipocortin 1 (LC1) mimicked the inhibitory effects of glucocorticoids on cytokine-induced HPA axis activation.

Conclusions:

  • Cytokines significantly influence the HPA axis.
  • Glucocorticoids and LC1 play a key role in modulating the neuroendocrine-immune system interaction.
  • This interplay is vital for host defense in health and disease.